Carole Chambers

1.0k total citations
58 papers, 677 citations indexed

About

Carole Chambers is a scholar working on Oncology, Geriatrics and Gerontology and Economics and Econometrics. According to data from OpenAlex, Carole Chambers has authored 58 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Geriatrics and Gerontology and 15 papers in Economics and Econometrics. Recurrent topics in Carole Chambers's work include Pharmaceutical Practices and Patient Outcomes (14 papers), Pharmaceutical studies and practices (13 papers) and Safe Handling of Antineoplastic Drugs (12 papers). Carole Chambers is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (14 papers), Pharmaceutical studies and practices (13 papers) and Safe Handling of Antineoplastic Drugs (12 papers). Carole Chambers collaborates with scholars based in Canada, United States and Australia. Carole Chambers's co-authors include Sunita Ghosh, Michael B. Sawyer, Michael P. Chu, Peter J Gilbar, Susan Jane Bigelow, Grace Lai–Hung Wong, Deonne Dersch‐Mills, Allen J. Vaida, Christina Kim and Randeep Sangha and has published in prestigious journals such as Journal of Clinical Oncology, Radiotherapy and Oncology and Clinical Nutrition.

In The Last Decade

Carole Chambers

56 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carole Chambers Canada 17 205 183 151 127 111 58 677
Vérane Schwiertz France 14 151 0.7× 47 0.3× 103 0.7× 170 1.3× 64 0.6× 31 607
John Valgus United States 14 88 0.4× 32 0.2× 174 1.2× 252 2.0× 31 0.3× 36 643
Jim Siderov Australia 11 94 0.5× 22 0.1× 104 0.7× 86 0.7× 111 1.0× 37 372
Miguel Ángel Calleja‐Hernández Spain 19 256 1.2× 159 0.9× 93 0.6× 153 1.2× 7 0.1× 75 1.0k
P.-J. Souquet France 15 788 3.8× 748 4.1× 45 0.3× 86 0.7× 31 0.3× 66 1.2k
Benyam Muluneh United States 12 129 0.6× 46 0.3× 93 0.6× 114 0.9× 24 0.2× 58 458
Fabrice Smieliauskas United States 13 120 0.6× 83 0.5× 49 0.3× 19 0.1× 11 0.1× 28 640
Mathieu Boulin France 17 140 0.7× 102 0.6× 25 0.2× 51 0.4× 5 0.0× 57 676
Rebecca L. Olin United States 16 454 2.2× 112 0.6× 154 1.0× 237 1.9× 3 0.0× 61 1.1k
Eric M. Tichy United States 14 50 0.2× 47 0.3× 175 1.2× 87 0.7× 3 0.0× 40 615

Countries citing papers authored by Carole Chambers

Since Specialization
Citations

This map shows the geographic impact of Carole Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Chambers more than expected).

Fields of papers citing papers by Carole Chambers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Chambers. The network helps show where Carole Chambers may publish in the future.

Co-authorship network of co-authors of Carole Chambers

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Chambers. A scholar is included among the top collaborators of Carole Chambers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Chambers. Carole Chambers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chambers, Carole, et al.. (2021). Education strategy for the implementation of oncology biosimilars essential for operational and patient safety in Alberta, Canada. Journal of Oncology Pharmacy Practice. 27(5). 1189–1194. 1 indexed citations
3.
Chambers, Carole, et al.. (2021). Case report: Proton pump inhibitor drug-related problem in pancreatic cancer patient unmasks pancreatic enzyme insufficiency. Journal of Oncology Pharmacy Practice. 28(2). 457–461. 1 indexed citations
4.
Joseph, Kurian, Verònica Alba, Larissa J. Vos, et al.. (2020). Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study. Radiotherapy and Oncology. 154. 93–100. 17 indexed citations
5.
Mayo, Patrick, et al.. (2019). The impact of palliative care consults on deprescribing in palliative cancer patients. Supportive Care in Cancer. 28(9). 4107–4113. 19 indexed citations
6.
Wong, Grace Lai–Hung, Michael P. Chu, Deonne Dersch‐Mills, et al.. (2018). Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer. Clinical Colorectal Cancer. 18(1). 72–79. 39 indexed citations
7.
Chambers, Carole, et al.. (2018). Centralized preparation of chemotherapy for remote administration. Journal of Oncology Pharmacy Practice. 25(5). 1174–1181. 1 indexed citations
8.
Gilbar, Peter J, et al.. (2018). How can the use of closed system transfer devices to facilitate sharing of drug vials be optimised to achieve maximum cost savings?. Journal of Oncology Pharmacy Practice. 25(1). 205–209. 13 indexed citations
9.
Tang, Patricia A., Annette E. Hay, Chris J. O’Callaghan, et al.. (2016). Estimation of Drug Cost Avoidance and Pathology Cost Avoidance through Participation in NCIC Clinical Trials Group Phase III Clinical Trials in Canada. Current Oncology. 23(11). 7–13. 15 indexed citations
10.
Sun, Julia, Christina Kim, Michael P. Chu, et al.. (2015). Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients. Clinical Colorectal Cancer. 15(3). 257–263. 45 indexed citations
11.
Chu, Michael P., Sunita Ghosh, Carole Chambers, et al.. (2014). Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 16(1). 33–39. 80 indexed citations
12.
Vaida, Allen J., et al.. (2014). Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology. Journal of Oncology Pharmacy Practice. 21(1). 26–35. 9 indexed citations
13.
Chambers, Carole, et al.. (2014). Expanding the role of clinical pharmacists in community oncology practice results of implementation at the Jack ady Cancer Clinic. 2 indexed citations
14.
Fairchild, Alysa, et al.. (2011). Optimizing pain relief in a specialized outpatient palliative radiotherapy clinic: Contributions of a clinical pharmacist. Journal of Oncology Pharmacy Practice. 18(1). 76–83. 25 indexed citations
15.
Chambers, Carole, et al.. (2010). Look-alike, sound-alike drugs in oncology. Journal of Oncology Pharmacy Practice. 17(2). 104–118. 14 indexed citations
16.
Sinclair, Shane, et al.. (2008). Accounting for reasonableness: Exploring the personal internal framework affecting decisions about cancer drug funding. Health Policy. 86(2-3). 381–390. 15 indexed citations
17.
Chambers, Carole, et al.. (2008). Efficacy vs. effectiveness — docetaxel and prednisone in hormone refractory prostate cancer. Journal of Oncology Pharmacy Practice. 14(1). 45–49. 7 indexed citations
18.
Chambers, Carole, et al.. (2003). Implementation of a telephone callback service for ambulatory oncology patients. Journal of Oncology Pharmacy Practice. 9(1). 21–28. 4 indexed citations
19.
Chambers, Carole, et al.. (1995). An evaluation of verbal and written methods in counselling cancer patients.. PubMed. 48(2). 98–9. 1 indexed citations
20.
Davies, Neal M., et al.. (1992). Comprehensive clinical pharmacy documentation in an out-patient cancer facility.. PubMed. 45(3). 107–11. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vérane Schwiertz Breakdown of academic impact, for papers by John Valgus Breakdown of academic impact, for papers by Jim Siderov Breakdown of academic impact, for papers by Miguel Ángel Calleja‐Hernández Breakdown of academic impact, for papers by P.-J. Souquet Breakdown of academic impact, for papers by Benyam Muluneh Breakdown of academic impact, for papers by Fabrice Smieliauskas Breakdown of academic impact, for papers by Mathieu Boulin Breakdown of academic impact, for papers by Rebecca L. Olin Breakdown of academic impact, for papers by Eric M. Tichy
Rankless by CCL
2026